Navigation Links
Lipitor Lawsuit News: US Spending on Drugs Fell For First Time in 2012, Notes Rottenstein Law Group LLP

(PRWEB) May 09, 2013

For the first time in 55 years, spending on medications in the United States has dropped, in part because of patent expirations for popular drugs such as Lipitor.* The Rottenstein Law Group LLP, a Lipitor law firm, offers its opinion on what this means for those who seek to file Lipitor lawsuits because they suffered from Lipitor-induced diabetes.

Pfizer lost patent protection for Lipitor in 2011, which led to other manufacturers’ selling cheaper generic versions of the drug. Given the great number of Lipitor users, that switch to generic plays a large role in reduced spending, according to a May 9 Reuters report.

But despite the availability of inexpensive Lipitor, Rottenstein Law Group LLP principal Rochelle Rottenstein notes that studies have been released that indicate there could be some serious risks that go along with using Lipitor. She cites a January 2012 study in JAMA: Internal Medicine that indicated there is a potential link between statins and a Type 2 diabetes risk in women.**

“Even though generics present a cheaper alternative, there are still some people buying name-brand Lipitor,” Rottenstein said. “Those people are at risk of suffering the alleged side effects that could make them eligible to file a lawsuit.”

Plaintiffs across the United States have filed lawsuits, many of which are under consideration for consolidation into a multidistrict litigation for efficient pretrial proceedings (In re Lipitor (Atorvastatin) Litigation, MDL No. 2459 (JPML)).

The Rottenstein Law Group LLP’s Lipitor Lawsuit Information Center offers a comprehensive look at Lipitor side effects and how to file a Lipitor lawsuit.



For the latest news on defective medications and medical devices and related lawsuits, visit the Rottenstein Law Group LLP’s Injury Lawyer Newswire at Readers can subscribe to the news site’s stories and videos to stay on top of personal injury news.

The Rottenstein Law Group LLP is a New York-based firm that represents clients nationwide in mass tort actions. The firm was founded by Rochelle Rottenstein, who has more than two decades of experience as a lawyer, to represent clients hurt by defective medical devices and drugs. (Attorney advertising. Prior results do not guarantee a similar outcome.)

The Rottenstein Law Group LLP
Rochelle Rottenstein, Esq.
321 W. 44th Street
# 804
New York NY 10036
(212) 933-9500 (office phone)
(212) 933-9980 (facsimile)
rochelle (at) rotlaw (dot) com

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Lipitor Diabetes Lawsuit Filed by South Carolina Woman Who Developed Type 2 Diabetes Allegedly Due to Lipitor Use, Alonso Krangle Investigating
2. Lipitor Lawsuit News: Rottenstein Law Group Comments on FDA Approval of New Drug With Lipitor Compound
3. Issues Report on Prostate Health Claim Lawsuits and Propecia Side Effect Litigation
4. The Law Office of Wolf & Pravato, The Alters Firm and Morelli Ratner File Class Action Lawsuit Against Global Spray Foam Manufacturer
5. National Actos Attorneys File Lawsuit on Behalf of Louisiana Woman who Developed Bladder Cancer Allegedly Due to The Diabetes Drug Actos
6. New Lawsuit Alleges Teen Molestation by Ex-Deputy
7. Actos Bladder Cancer Lawsuit Filed in Louisiana Alleging Woman Used Diabetes Medication and Contracted Bladder Cancer, Consumer Justice Foundation Reports
8. New Lawsuit on Propecia: Severe Adverse Events
9. New Lawsuit on Accutane Crohn’s Disease: Severe Adverse Events
10. New Lawsuit alleges Actos caused Bladder Cancer
11. DrugRisk Center Announces Court Postponement of NuvaRing Lawsuits
Post Your Comments:
(Date:11/26/2015)... , ... November 26, 2015 , ... Jobs in hospital ... healthcare professionals and offered by healthcare staffing agency Aureus Medical Group . ... month of October 2015 among those searching for healthcare jobs through the company’s website, ...
(Date:11/26/2015)... ... November 26, 2015 , ... WorldCare ... participated in the 61st annual Employee Benefits Conference. The Employee Benefits Conference was ... November 8th through Wednesday, November 11th, 2015. The conference was held at the ...
(Date:11/26/2015)... , ... November 26, 2015 ... ... platform for mental health and wellness consultation, has collaborated with Women’s Web ... address their reader’s queries on topics on mental and emotional well-being relationship, ...
(Date:11/25/2015)... ... November 25, 2015 , ... Additional breast ... found on mammography, according to a study published online in the journal Radiology. ... on mammography may necessitate a change in treatment. , Breast MRI is the ...
(Date:11/25/2015)... ... 25, 2015 , ... The holiday season is jam-packed with ... palates of attendees is of the utmost importance. Whether you are cooking at ... these recipes a try this holiday season. , Turkey Croquettes , ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... , November 26, 2015 ... Juntendo universitetssjukhus ser potential att använda ... magnetresonansbilder (MR-bilder) för patienter med multipel ... ett forskningsavtal med SyntheticMR AB för att ... forskningsprojekt på sjukhuset. Med SyMRI kan man ...
(Date:11/26/2015)... 26, 2015 ... adds "Global Repaglinide Industry 2015 ... on China Repaglinide Market, 2010-2019" reports ... and information to its online business ... . --> ...
(Date:11/26/2015)... DUBLIN , November 26, 2015 /PRNewswire/ ... the addition of the "Radioimmunoassay Market ... User (Hospital, Pharmaceutical Industry, Academics, Clinical Diagnostic ... - Global Forecast to 2020" report ... ) has announced the addition of the ...
Breaking Medicine Technology: